To further corroborate the role of miR-27a-3p/NOVA1 axis in cardiac hypertrophy, we treated H9c2 cells with Ang II, in the presence of miR-27a-3p inhibitor and NOVA1 siRNA. The gene discussed is NOVA1; the disease is cardiac hypertrophy.